Anthony Cannavicci

Anthony Cannavicci, PhD, currently serves as an Oncology Field Medical Affairs Scientist (Medical Science Liaison) at Pfizer, where responsibilities include acting as a medical and scientific liaison for breast and prostate cancer. Previously, Anthony was a Specialty Care Field Medical Affairs Scientist at Pfizer, focusing on rare hematology and neuromuscular diseases, fostering key opinion leader relationships, and implementing strategic medical plans. In addition, Anthony is the President of HHT Canada THH, a charity dedicated to HHT awareness and advocacy. Academic credentials include a PhD in Medical Science from the University of Toronto, where a Master's research component also took place, and a Bachelor's degree in Molecular Biology/Genetics from York University. Notable past roles include serving as a Scientific Advisor for Cure HHT and various research assistant positions at St. Michael's Hospital and Mount Sinai Hospital.